Select Page

Home / Share Price History /

Sun Pharma Advanced Research Share Price History (2003 To 2026)

Sun Pharma Advanced Research Share Price History (2003 To 2026)

Show Table of Contents

Sun Pharma Advanced Research Company Share Highlights

As of Mon 15 Jun 2026, Sun Pharma Advanced Research Company Share price is ₹229.03 which is ₹19.72 below 52-week high of ₹248.75 and ₹121.03 above 52-week low of ₹108

52-Week High Low

  • Sun Pharma Advanced Research Company 52-Week High is ₹248.75 occurred on Tue 26 May 2026
  • Sun Pharma Advanced Research Company 52-Week Low is ₹108 occurred on Mon 23 Mar 2026

All Time High

  • The all-time high or the highest price that Sun Pharma Advanced Research Company shares have ever touched was ₹875 and this occurred on Apr 2006.
  • The highest closing price at which Sun Pharma Advanced Research Company shares have ever closed was ₹866.1 recorded on Apr 2006.

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our Telegram channel

Your phone number will be HIDDEN to other users.

Sun Pharma Advanced Research Company Recent Performance

Over the past 15 trading days, the value of Sun Pharma Advanced Research Company's stock has decreased by ₹6.54 (-2.78%).

From 26 May 2026 to 15 Jun 2026, it reached a high of ₹248.75 and a low of ₹194.10.

Sun Pharma Advanced Research Company Share Price Chart From 2007 to 2026

Sun Pharma Advanced Research Company Share Price History Table From 2007 to 2026

Year Sun Pharma Advanced Research Company YOY Chg% ↑High - ↓Low
2026 ₹223.76 66.4% ↑ ₹248.75
↓ ₹108
2025 ₹134.44 -33.0% ↑ ₹208.3
↓ ₹109.3
2024 ₹200.55 -30.1% ↑ ₹472.8
↓ ₹189.75
2023 ₹286.8 37.5% ↑ ₹291
↓ ₹162.1
2022 ₹208.6 -27.3% ↑ ₹349
↓ ₹170.45
2021 ₹286.89 48.1% ↑ ₹312
↓ ₹141
2020 ₹193.75 24.0% ↑ ₹210.9
↓ ₹81
2019 ₹156.19 -16.9% ↑ ₹203.9
↓ ₹112.3
2018 ₹188.05 -63.0% ↑ ₹532
↓ ₹187.2
2017 ₹507.7 66.6% ↑ ₹527
↓ ₹272
2016 ₹304.8 -9.7% ↑ ₹414.9
↓ ₹243.54
2015 ₹337.45 82.0% ↑ ₹593.96
↓ ₹184.2
2014 ₹185.39 16.0% ↑ ₹217.17
↓ ₹142.78
2013 ₹159.86 19.1% ↑ ₹178.54
↓ ₹103.3
2012 ₹134.24 82.9% ↑ ₹140.54
↓ ₹65.06
2011 ₹73.38 -20.0% ↑ ₹99.32
↓ ₹62.92
2010 ₹91.75 14.2% ↑ ₹108.75
↓ ₹71.72
2009 ₹80.31 89.6% ↑ ₹96.14
↓ ₹39.77
2008 ₹42.36 -73.1% ↑ ₹162.19
↓ ₹35.17
2007 ₹157.26 -45.9% ↑ ₹290.67
↓ ₹60.43
2006 ₹290.67 0.0% ↑ ₹290.67
↓ ₹290.67
2005 ₹290.67 0.0% ↑ ₹290.67
↓ ₹290.67
2004 ₹290.67 0.0% ↑ ₹290.67
↓ ₹290.67
2003 ₹290.67 - ↑ ₹309.73
↓ ₹287.25

Analyzing the Impact of Investing in Sun Pharma Advanced Research Company

Sun Pharma Advanced Research Company share price in 2003 was ₹290.67. If you had invested ₹10,000 in Sun Pharma Advanced Research Company shares in 2003, in 23 years, your investment would have declined to ₹7,698.07 by 2026. This represents a negative return of -23.0% with a CAGR of -1.1%.

Sun Pharma Advanced Research Company Share Returns In Last 5 Years

  • Its highest stock price in the last 5 years was: ₹472.80 and lowest was: ₹108.00
  • Sun Pharma Advanced Research Company Share price in 2022 was ₹208.60
  • By 2026, its share price rose to ₹223.76
  • It gave a positive return of 7.3% with a CAGR of 1.4% over the last 5 years
  • If you had invested ₹10,000 in Sun Pharma Advanced Research Company in 2022 then in 5 years, your investment would have grown to ₹10,726.74 by 2026

Sun Pharma Advanced Research Company Share Returns In Last 10 Years

  • Its highest stock price in the last 10 years was: ₹532.00 and lowest was: ₹81.00
  • Sun Pharma Advanced Research Company Share price in 2017 was ₹507.70
  • By 2026, its share price dropped to ₹223.76
  • It gave a negative return of -55.9% with a CAGR of -7.9% over the last 10 years
  • If you had invested ₹10,000 in Sun Pharma Advanced Research Company in 2017 then in 10 years, your investment would have declined to ₹4,407.32 by 2026

Sun Pharma Advanced Research Company Share Returns In Last 15 Years

  • Its highest stock price in the last 15 years was: ₹593.96 and lowest was: ₹65.07
  • Sun Pharma Advanced Research Company Share price in 2012 was ₹134.24
  • By 2026, its share price rose to ₹223.76
  • It gave a positive return of 66.7% with a CAGR of 3.5% over the last 15 years
  • If you had invested ₹10,000 in Sun Pharma Advanced Research Company in 2012 then in 15 years, your investment would have grown to ₹16,668.65 by 2026

Sun Pharma Advanced Research Company Share Returns In Last 20 Years

  • Its highest stock price in the last 20 years was: ₹593.96 and lowest was: ₹35.17
  • Sun Pharma Advanced Research Company Share price in 2007 was ₹157.26
  • By 2026, its share price rose to ₹223.76
  • It gave a positive return of 42.3% with a CAGR of 1.8% over the last 20 years
  • If you had invested ₹10,000 in Sun Pharma Advanced Research Company in 2007 then in 20 years, your investment would have grown to ₹14,228.66 by 2026

Sun Pharma Advanced Research Company Returns vs Bank FD Returns

Investment Type Initial Amount Final Value Total Returns
Sun Pharma Advanced Research Company Shares ₹10,000 ₹7,698.07 -23.0%
Bank FD (Simple Interest) ₹10,000 ₹23,800 138.0%
Bank FD (Compound Interest) ₹10,000 ₹38,197.49 282.0%

Short Info About Sun Pharma Advanced Research Company

Overview of Sun Pharma Advanced Research Company Limited Sun Pharma Advanced Research Company Limited is a leading biopharmaceutical company dedicated to research and development of innovative pharmaceutical products. Founded in 2006 and headquartered in Mumbai, India, the company has a... Read More

Overview of Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited is a leading biopharmaceutical company dedicated to research and development of innovative pharmaceutical products. Founded in 2006 and headquartered in Mumbai, India, the company has a strong presence in India and internationally.

Sun Pharma Advanced Research is renowned for its diverse product portfolio, with a focus on therapeutics for oncology, neurodegeneration, ophthalmology, dermatology, and immunology.

Notable Products

  • Elepsia XR (anti-epileptic)
  • Xelpros (glaucoma treatment)
  • Phenobarbital injection (neonatal seizures)

Development Pipeline

The company is committed to expanding its product range through ongoing research and development. Some key pipeline candidates include:

  • SDN-037 (ocular surgery inflammation)
  • PDP-716 (glaucoma)
  • Vodobatinib (chronic myelogenous leukemia and Parkinson's disease)
  • SCD-044 (psoriasis and atopic dermatitis)
  • SCO-120 (breast cancer)

About The Author

Nippun

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, and let’s learn from each other. Connect on linkedin